NEW YORK, June 29, 2024 (GLOBE NEWSWIRE) –
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Inari Medical, Inc. (NASDAQ: NARI) between February 24, 2022 and February 28, 2024, both dates inclusive (the “Litigation Period”), of the important July 12, 2024, lead plaintiff deadline.
SO WHAT: If you purchased Inari Medical common stock during the Class Period, you may be entitled to compensation without payment of any out-of-pocket fees or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join the Inari Medical class action lawsuit, go to https://rosenlegal.com/submit-form/?case_id=22855 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information about the class action lawsuit. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court by 12 July 2024 at the latestA lead plaintiff is a representative party directing the litigation on behalf of other class members.
WHY ROSEN LAW: We encourage investors to select qualified advisors with a track record of success in senior leadership roles. Often, the firms issuing the advertisements do not have comparable experience, resources or significant recognition from their peers. Many of these firms do not actually litigate securities class action lawsuits, but rather act as intermediaries, referring clients or working with law firms that actually litigate the cases in court. Choose your lawyer wisely. The Rosen Law Firm represents investors around the world and focuses on class action and shareholder litigation. The Rosen Law Firm has achieved the largest securities class action settlement against a Chinese company. The Rosen Law Firm was ranked No. 1 by ISS Securities Class Action Services in 2017 for number of securities class action settlements. The firm has been ranked in the top four every year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone, the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named a Titan of Plaintiffs’ Bar by law360. Many of the firm’s attorneys have received awards from Lawdragon and Super Lawyers.
CASE DETAILS: According to the complaint, throughout the Class Period, defendants touted Inari’s “record sales” that were supposedly due to “the strength of our core (venous thromboembolism (“VTE”) business.” However, defendants failed to disclose that a significant portion of their expenses were used to improperly compensate medical personnel for using Inari products. In truth, while defendants spoke positively about Inari Medical’s growth prospects, they engaged in illegal business practices. Specifically, Inari Medical improperly compensated medical personnel in violation of the federal Anti-Kickback Act and the Civil False Statements Act. Defendants also misled investors about business expenses to conceal their illegal conduct. When the true details came to market, the complaint alleges, investors suffered harm.
To join the Inari Medical class action lawsuit, go to https://rosenlegal.com/submit-form/?case_id=22855 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information about the class action lawsuit.
No class action has been certified. Until a class action is certified, you will not be represented by counsel unless you hire one. You may select counsel of your choice. You may also remain as an absent class member and take no action at this time. An investor’s ability to share in any potential future recovery is not dependent on serving as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney advertising. Past results do not guarantee a similar result.
——————————-
Contact information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Law Firm of Rosen, PA
275 Madison Avenue, 40th floor
New York, NY 10016
Phone: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
www.rosenlegal.com
